GT Metabolic Solutions has completed the first magnetic compression anastomosis cases in the US using the MagDI System, the procedures were performed by Dr Helmuth Billy (Ventura Advanced Surgical Associates) and his team at Community Memorial Healthcare, Ventura County, CA.
"Bariatric surgery is well known to be the most reliable and effective therapy we have for the treatment of morbid obesity,” said Billy. “Now, with the successful use of magnetic anastomosis I can lower the risk of complications like bleeding and leakage to virtually zero. Our most effective operations for the treatment of obesity are now safer than ever thanks to magnetic compression anastomosis.”
Magnetic compression anastomosis is designed to mitigate the need for incision to the bowel, reduce user technical variability during a procedure, and be naturally excreted from the body. According to the company, traditional anastomotic devices like staples or sutures can be difficult to apply in confined spaces during minimally invasive surgical procedures and can cause trauma by cutting or piercing the bowel tissue and leaves foreign material behind.
The company’s magnetic compression solution - delayed anastomosis technology (DAT) - allows surgeons to create consistent anastomosis while helping minimising potential complications, such as leaks and bleeds, in challenging applications. The solution democratises the surgical approach to anastomosis.
The MagDI System is composed of the GT Metabolic linear DI magnets, the GT Metabolic delivery system, and the GT Metabolic laparoscopic positioning device (LPD). During the MagDI procedure two linear magnets are delivered orogastrically to the patient. The magnets are positioned laparoscopically and self-align through the small bowel. After several weeks the magnets compress the tissue fusing together forming an anastomosis. The magnets detach and are expressed naturally.
The anastomosis created with magnet compressions happens without the cutting or piercing of intestinal tissue that occurs with the current practice of stapling or suturing. The MagDI System is designed for more consistent tissue alignment, central necrosis, and circumferential healing while leaving no foreign materials behind to impede the natural tissue healing process.
"For those seeking new tools for less invasive procedures, the MagDI System is the much-anticipated evolution in bariatrics,” said Ronald Galovich, Vice President Sales & Marketing, GT Metabolic Solutions. “The industry has never been more ready for this technology than it is today. GT Metabolic will now accelerate U.S. market release in collaboration with leading surgeons and hospital centres.”
Comments